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Introduction
Saving Mothers, Giving Life (SMGL) is a 
5-year initiative designed to rapidly reduce 
deaths related to pregnancy and childbirth 
by implementing multiple evidence-based 
interventions in high-mortality settings. The 
initiative was launched by Secretary of State 
Hillary Clinton in 2012 as a public-private 
partnership1 to prevent maternal and newborn 
deaths as part of the Global Health Initiative 
(GHI) and to support achievement of the 
United Nations’ Millennium Development 
Goals (MDG). 
The SMGL partnership aspired to reduce 
maternal mortality by 50% in targeted districts 
of Uganda and Zambia. To achieve this goal, 
SMGL interventions focused on the critical 
period of labor, delivery, and 48 hours 
postpartum, when most maternal deaths 
and about half of newborn deaths occur. 
SMGL strived to improve access to, 
demand for, and the quality of Emergency 
Obstetric and Newborn Care (EmONC).2 
It also sought to strengthen links to other 
essential services for women and children, 
including HIV prevention, care, and treatment 
and family planning. SMGL began in eight 
districts, four each in Uganda and Zambia. 
Phase 1 (the pilot phase) activities 
took place from June 2012 through May 
2013. SMGL Country Teams, with multiple 
implementing partner organizations, conducted 
routine monitoring during the first year of 
the project, and performed baseline and 
endline assessments before and after Phase 
1. The first year of SMGL was designed to 
provide “proof of concept” that the package of 
interventions was effective in achieving better 
health outcomes for women and their babies.
Phase 1 was based on the premise that 
existing program platforms could be leveraged 
to improve maternal and neonatal health 
outcomes during labor, delivery, and 48 hours 
postpartum. The SMGL platform built on 
existing host country government programs 
and systems-strengthening efforts to address 
maternal and child health and to achieve MDGs 
4 and 5. Additional existing platforms included 
those established through the Presidents 
Emergency Plan for AIDS Relief (PEPFAR), US 
Agency for International Development (USAID), 
CDC, and other global health initiatives. 
Leveraging these existing efforts, SMGL  
was able to implement proven interventions for 
EmONC and accessible, high-quality obstetric 
care and essential newborn care. SMGL was 
designed to strengthen the existing health 
network within each district to ensure that 
women could receive quality facility-based care 
within 2 hours of the onset of labor or obstetric 
emergencies. SMGL’s essential components and 
concepts are shown in Box 1. 
1. Current partners are the American College of Obstetricians and Gynecologists, Every Mother Counts, Merck for Mothers, the Government of Norway,  
Project CURE, and the US Government [Centers for Disease Control and Prevention (CDC), US Agency for International Development (USAID), Peace  
Corps, US Department of Defense, and US Office of the Global AIDS Coordinator (OGAC)]. The governments of Uganda and Zambia were central to  
the partnership and all activities. 
2. Emergency Obstetric and Newborn Care (EmONC) includes a set of 9 life-saving interventions, known as “signal functions” that the World Health Organi-
zation has recommended to reduce maternal and neonatal mortality. Basic Emergency Obstetric and Newborn Care (BEmONC) facilities are those that 
performed at least 6 of 7 functions in the 3 preceding months (administered parenteral antibiotics; parenteral oxytocic drugs; parenteral anticonvulsants 
for pre-eclampsia and eclampsia; performed manual removal of placenta; removal of retained products; and performed assisted vaginal delivery). Com-
prehensive Emergency Obstetric and Newborn Care (CEmONC) facilities are those that performed BEmONC signal functions and two additional functions: 
Cesarean sections and blood transfusions. 
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Box 1. The SMGL Model
To save mothers’ lives, SMGL uses a  
health district network strengthening  
strategy to provide timely, high-quality  
obstetric care to all pregnant women and  
newborn care to babies. The strategy 
promotes adequate coverage of Emergency 
Obstetric and Newborn Care (EmONC), a 
package of life-saving interventions designed 
to manage direct obstetric complications 
that cause the majority of maternal deaths.
SMGL’s essential components and 
concepts include the following:
A comprehensive approach. Women’s lives 
cannot be saved by any one intervention 
alone. Reducing maternal mortality requires a 
solution that addresses multiple health system 
issues at multiple levels. SMGL uses evidence-
based interventions that are designed to 
address three dangerous delays that pregnant 
women face in childbirth: delays in deciding 
to seek care for an obstetric emergency, delays 
in reaching a health facility in time, and delays 
in receiving quality care at health facilities.
An adequate number of high-quality 
delivery facilities, including EmONC, 
which are accessible within 2 hours of the 
onset of labor or obstetric emergencies.
An integrated communication-
transportation system that functions 24 
hours a day/7 days a week to encourage 
and enable pregnant women to use delivery 
care facilities. This system should include 
community outreach and interventions 
that increase awareness of these facilities.
An adequate number of skilled birth 
attendants who can provide quality care 
for normal delivery and who are able to 
identify and refer obstetric emergencies.
A functional supply chain system to 
ensure that facilities have the equipment, 
supplies, commodities, and drugs they need 
to deliver high-quality obstetric care.
A system that accurately records every 
birth and maternal and neonatal death.
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The governments of Uganda and Zambia 
were already investing in the development of 
district health network models. SMGL packages 
of interventions were designed to capitalize 
on and expand these efforts (Figure 1). 
SMGL was conceived as a phased initiative, 
with the first interventions introduced in eight 
districts (four each in Uganda and Zambia). 
In subsequent Phases, SMGL would apply 
lessons learned in the pilot districts, and 
expand to new districts and countries. Although 
Phase 1 officially began in June 2012, needs 
assessments and program planning activities 
were conducted during the preceding 18 
months. Preparation for SMGL interventions 
took place in early 2012, with most interventions 
fully operational beginning in June 2012. 
Figure 1. SMGL Packages of Interventions  
Designed to Strengthen District Health Networks
Increase access to high- 
impact maternal health 
services




demand for maternal 
health services
Health systems for basic 
& emergency obstetric 
care improvement
volunteers
• Support transportation network
•Support mobile technology communications 
•Upgrade facilities
•Train/mentor/supervise EmONC
•Mentor/supervise basic obstetric & newborn care
• Strengthen community feedback, health center 
•Promote women-friendly birthing centers
•Mobilize communities to promote institutional delivery
• Support mother-baby packs
•Behavior change communication
•Use mobile technology
• Strengthen referral system 
• Strengthen essential equipment and commodities 
• Strengthen blood supply and management
•Maternal death surveillance and response
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Monitoring and Evaluation for SMGL
Extensive monitoring and evaluation (M&E) of 
SMGL during Phase 1 was essential to assess 
potential changes in the key indicators closely 
related to maternal and neonatal mortality. 
SMGL M&E efforts drew upon the experience 
of existing global initiatives designed to 
standardize data-collection methods for 
monitoring interventions, making decisions, 
and developing health policies related to 
maternal and neonatal outcomes and care. 
SMGL M&E sought to contribute to 
routine registration of pregnant women, 
births, and maternal and newborn deaths 
by improving existing data systems in 
facilities and communities. In addition, 
SMGL tracked indicators closely related to 




The availability of health facility delivery  
and EmONC. 
Access to and use of these services.
Provision of additional essential services, such 
as HIV testing and treatment for women and 
newborns, and postpartum family planning. 
Data systems that documented maternal 
and neonatal health outcomes accurately and 
completely were needed to document SMGL 
indicators. Since the necessary data systems 
were only partially in place, SMGL required 
intensive efforts to scale up or establish 
community and facility-based data collection. 
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Guiding Principles of SMGL M&E 
Early in the development of SMGL M&E 
activities, the two pilot country teams along 
with Ministry of Health (MOH) officials, 
identified the goal of harnessing SMGL M&E 
efforts to improve existing data systems or 
establish community and facility-based data 
collection, build capacity in data collection and 
analysis, and extract information that could 
be useful beyond the SMGL Phase 1 effort. 
To ensure that M&E efforts were aligned  
with the country’s existing data needs 
and priorities, the M&E teams adopted 
guiding principles for M&E (Figure 2). 
SMGL collaborating partners and 
governments were committed to employing 
existing data systems for SMGL to the greatest 
extent possible, avoiding the establishment 
of new parallel data collection. Nevertheless, 
enhancement of existing systems and creation 
of some data collection mechanisms were 
necessary to capture information needed for 
SMGL M&E. Because of the lack of systematic 
maternal mortality surveillance in the pilot 
districts before SMGL, documenting maternal 
deaths was the most resource-intensive 
and complex aspect of the M&E plan. 
Figure 2. SMGL Guiding Principles 
Promote country ownership
Strengthen existing data collection and  
analysis systems, and ensure their sustainability
Build the capacity of districts to improve M&E efforts
Develop a shared set of core indicators to track progress
Improve quality of data collection and analyses 
Ensure that M&E level of effort, personnel, and  
strategies match existing resources
Provide timely information for policy makers and decision makers, 
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SMGL Phase 1  
Monitoring and Evaluation Framework 
Prior to SMGL implementation, each country 
team developed an M&E framework. In 
order to harmonize indicators for the whole 
SMGL initiative, a headquarters (primarily 
in Washington, DC and Atlanta) M&E team 
comprised of representatives from CDC, USAID, 
and other SMGL partners worked with the 
country teams to review their frameworks. 
These initiative-wide SGML indicators 
drew upon the experience of existing major 
global initiatives aimed at standardizing and 
harmonizing data collection for monitoring, 
decision-making, and health policy in maternal 
and neonatal health care. They include the 
UN’s Interagency Group on Indicators that 
recommends measures to track progress on 
MDGs 4 and 5 across countries, the Countdown 
to 2015 for Maternal, Newborn and Child 
Survival, the United Nations Commission on 
Information and Accountability (COIA) for 
Women’s and Children’s Health, and the United 
States’ Global Health Initiative and its President’s 
Emergency Plan for AIDS Relief (PEPFAR). 
The SMGL M&E Results Framework included 
a range of indicators designed to measure 
program achievements in Phase 1. The indicators 
can be grouped into four broad categories:
Impact — such as changes in the number of 
maternal and newborn deaths.
Outcomes — such as percentage of deliveries in 
health facilities and rates for Cesarean sections. 
Outputs — such as the number of EmONC signal 
functions performed, HIV tests conducted, and 
PMTCT (prevention of mother-to-child HIV trans-
mission) services provided. 
Processes — such as hiring and training 
personnel, upgrading facilities, and stockpiling 
life-saving medicines. 
From the outset of SMGL, the partnership 
adopted an aspirational goal to reduce 
maternal mortality by 50% in districts where 
SMGL was implemented. Targets were not 
established for each SMGL indicator, but 
the SMGL initiative generally aspired to 
reach goals established by the World Health 
Organization (WHO), including availability 
of EmONC, met need for EmONC, and an 
appropriate range of the percentage of deliveries 
performed by Cesarean section (5–15%). 
To collect and analyze the necessary 
data for reporting on the variables in the 
SMGL Results Framework (Box 2, Page 
7), country and headquarters M&E teams 




How to measure indicators. 
How often to report. 
The available data sources. 
The teams attempted to articulate these 
specifications clearly from the outset of SMGL. 
However, more extensive guidance on indicator 
specifications at the outset, as well as standard 
data collection tools and approaches, would 
have benefitted subsequent efforts to harmonize 
SMGL M&E results across the two countries.
Some SMGL indicators could not be collected 
through either the existing or the new data 
systems put into place by SMGL. Community-
level data proved to be the most challenging 
and resource-intensive information to capture, 
because of the lack of existing data collection 
infrastructure. Additionally, some facility-
based information was not readily available 
or easily obtainable, including information 
such as the incidence of specific maternal 
complications and the frequency of use of 
specific medications or interventions. 
These “aspirational” indicators were set 
aside, with the expectation of expanding 
abilities to report on them in future phases 
of SMGL. The SMGL indicators list for Phase 1 
reporting shown in the Appendix demonstrates 
how the list of M&E indicators was expanded 
and refined over the course of Phase 1. 
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Box 2. SMGL Monitoring and Evaluation Results Framework 
SMGL Impact: Reduce maternal deaths by up to  
50% in targeted SMGL districts 
Reduced maternal mortality ratio
Reduced number of maternal deaths
Increased number of maternal lives saved
Reduced neonatal mortality rate 
Reduced number of neonatal death
Intermediate Outcomes
Increased availability/met need for Emergency Obstetric and Newborn Care (EmONC) 
Increased % of deliveries taking place in health facilities 
Increased Cesarean section Rate
Reduced Postpartum Hemorrhage Rate
Reduced Mother-to-child HIV transmission during delivery
Reduced EmONC Case Fatality rate (cause-specific) 
Increase the  
availability of quality  
institutional delivery,  
including EmONC
# of new health care workers 
who graduated from a pre-
service training institution
% of women delivering 
in EmONC facilities 
who are provided with 
prophylactic post-partum 
Oxytocin/ Uteronics
% of facilities where the 
7 signal functions that 
constitute Basic EmONC 
(BEmONC) are functional*
% of facilities where the 




* Compare to WHO standards 
Increase utilization of 
quality institutional 
delivery and met need 
for EmONC services 
% of women delivering  
in a facility
% of communities with 
functional health groups 
that promote institutional 
delivery
% of communities where 
pregnant women have 
access to functional 
transportation system or 
scheme for emergency 
referral 
Ensure women and their 
newborns are provided 
other necessary services 
% of women delivering  
in a facility that receive 
postpartum counseling on  
family planning
% of women delivering  
in a facility that receive  
postpartum family  
planning method
 % of pregnant women  
who were tested for HIV 
and know their result 
% of HIV-positive pregnant 
women who received 
antiretrovirals to reduce 
risk of mother-to-child 
transmission 
% of infants born to 
HIV-positive pregnant 
women who are started 
on Cotrimoxazole (CTX) 
prophylaxis within two 
months of birth 
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An independent evaluation of SMGL Phase 1 
was conducted by Columbia University Mailman 
School of Public Health, commissioned by Merck 
for Mothers. This activity, completed in two 
waves of data collection, provided additional 
valuable information to monitor and evaluate 
SMGL, such as the numbers of health workers 
hired and trained, transportation vouchers 
distributed and redeemed, health care facilities 
upgraded, ambulances acquired, and other 
similar indicators of SMGL inputs and selected 
outputs. Although these indicators were not 
originally captured in the SMGL M&E Results 
Framework, they provide an additional and 
valuable source of information to evaluate SMGL. 
SMGL M&E Measurement Approaches 
Activities to capture the SMGL indicators were 
implemented in both Uganda and Zambia from 
the onset of the initiative. The central objective 
was to assess the impact of the SMGL strategies 
to reduce maternal and neonatal deaths in the 
pilot districts during Phase 1. As indicated in 
Figure 3, the M&E methods and data systems 
employed by the two countries can be divided 
into two main categories: 
 
 
Community-based data collection. 
Facility-based data collection. 
Within each of these categories, efforts 
focused on establishing baseline levels of key 
indicators before SMGL implementation began, 
and measuring the changes that occurred  
during Phase 1. Community-level 
data collection focused on
  First, establishing baseline maternal 
mortality ratios/numbers during 
the period immediately before 
SMGL implementation began. 
Figure 3. SMGL M&E Approaches Used 




Facility-based data collection to 




























Uganda     
Zambia    
M&E Methods
aReproductive Age Mortality Study
bHealth Management Information Systems
cPresident’s Emergency Plan for AIDS Relief
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  Subsequently identifying maternal 
deaths prospectively during SMGL 
Phase 1 in order to document change. 
Facility-based data collection included
 
 
Baseline and endline health facility 
assessments to document change in 
infrastructure, human resources, supplies/
equipment, and services. Baseline 
assessments were conducted in the months 
preceding the June 2012 beginning of the 
Phase 1 year, and endline assessments 
were carried out one month after the 
conclusion of the pilot year ( June 2013). 
Prospective tracking of maternal and 
neonatal outcomes documented in facilities 
in the form of tallies of events (aggregate) 
or more intensive facility outcome 
monitoring using individual-level records. 
To the greatest extent possible, SMGL used 
data already being collected at the district level 
through existing Health Management Information 
Systems (HMIS) employed by the country 
government, or through PEPFAR. A timeline 
overview for the implementation of SMGL data 
collection activities is shown in Figure 4. 
Results from additional data collection 
efforts carried out by SMGL partners will be 




An ethnographic study conducted in Zambia 
to examine the socio-cultural norms and 
practices around pregnancy, childbirth, and 
accessing and using maternal care services.
An expenditure study conducted by USAID 
and the Futures Group in both pilot 
countries to obtain data about the level and 
types of investment needed to strengthen 
maternal and newborn health services within 
the eight districts that implemented SMGL.
Data gathered by private-sector partners 
on their SMGL-related activities. 
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SMGL Phase 1 Topic-Specific Reports 
In addition to this report, which describes the 
SMGL Phase 1 M&E efforts, three accompanying 
technical reports provide in-depth data analysis 
of findings from the main components of the 
SMGL community-based and facility-based 
evaluations. Each contains an introductory 
section that describes the data sources and 
methods on which the results are based, as well 
as background information of importance to the 
specific topic. The Saving Mothers Giving Life 
Phase 1 Monitoring and Evaluation Reports are:
 
 
Maternal Mortality focuses on results from 
baseline and prospective maternal mortality 
identification activities and summarizes 
the impact of SMGL on maternal mortality 
levels in the pilot districts during Phase 1. 
Results for Uganda reflect population-based 
changes in maternal mortality, whereas 
results for Zambia are restricted to changes 
in maternal deaths that occurred in facilities.
Emergency Obstetric and Newborn Care 
Access and Availability summarizes findings 
from the baseline and endline Health 
Facility Assessments that were conducted in 
all facilities that provided delivery services. 
The health facility assessments documented 
change in maternity care and EmONC, 
facility infrastructure, human resources, and 
other aspects of health service between pre-
intervention and end of Phase 1. Additionally, 
the report incorporates information from 
the Uganda District Health Information 
System (DHIS2) and the Health Management 
Information System (HMIS) in Zambia.
  Maternal and Perinatal Outcomes in 
Health Facilities focuses on the results of 
facility-based maternal and perinatal health 
outcome monitoring. Data were derived 
from routine reporting of aggregate numbers 
of maternal and infant health outcomes in 
health facilities (Zambia) and individual-
level data extracted from health facility 
records (Uganda, 16 CEmONC facilities). 
The three reports highlight findings derived 
from the priority indicators reported by each of 
the SMGL pilot countries shown in the SMGL 
M&E Results Framework and more detailed list 
of SMGL Reporting Indicators in the Appendix. 
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Data Limitations 
Measurement of SMGL M&E indicators  
required the pilot districts to redouble their 
efforts to address longstanding challenges in 
monitoring the health outcomes of mothers 
and infants that persist in low-resource 
settings around the world, including the lack 
of existing vital records systems. Therefore, the 
data underlying the four SMGL reports have 
limitations. For each data source, the reports 
outline specific data quality or coverage issues 
that should be taken into account when 
interpreting the results of SMGL Phase 1. 
The overarching goal of reducing maternal 
mortality by 50% implied the need to measure 
district-level maternal mortality at baseline and 
then track progress over the pilot year. Because 
of weak existing infrastructure in Uganda and 
Zambia for tracking maternal mortality through 
community-based data collection, extensive 
training, monitoring, and logistics were necessary 
to accomplish the goal of documenting every 
maternal death. 
Carrying out these activities in a short 
timeframe proved to be a major challenge 
in timing of data availability. Nevertheless, 
Uganda successfully produced robust 
community-level mortality information; Zambia 
established baseline maternal mortality data 
and documented deaths in facilities. These 
SMGL efforts to improve maternal mortality 
identification have led to heightened awareness 
and strengthened capacity. They also have laid 
the groundwork for ongoing Maternal Death 
Surveillance and Response (MDSR) systems. 
Similarly, the quality and completeness of 
both baseline and routine health facility data 
proved to be insufficient for SMGL monitoring 
and evaluation. Thus, SMGL put extra effort into 
increasing the quality of the existing routine data 
collection, and collected supplemental facility-
level data, which had not been anticipated 
when SMGL began. However, the benefits 
of this intensified attention to data quality 
in facilities are likely to be sustainable, and 
they should result in overall improvements in 
completeness and use of routine health facility 
data. Moreover, these efforts support the two 
governments’ priorities to strengthen their HMIS 
systems, such that increased quality of routine 
facility data is likely to result in improvements 
to the larger health information system.
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Achievements of Phase 1 M&E  
Systems Strengthening Approach 
SMGL brought about an unprecedented 
intensity of focus on documenting maternal 
deaths and on maternal and perinatal health 
outcomes in facilities and communities. SMGL 
M&E activities were instrumental in building 
capacity, strengthening existing data systems, and 
providing data for action. There are numerous 
examples of the benefits of SMGL Phase 1 M&E 
activities, including the following results.
Activating Community-Based Surveillance  
SMGL trained Village Health Team (VHT) 
workers in Uganda to identify and report 
potential maternal deaths at the community 
level. This resulted not only in data for 
SMGL, but also in a nascent community-
based system of surveillance of pregnancies 
and maternal deaths that could contribute 
to the Ugandan government’s goal of 
establishing a vital records system. 
Similarly in Zambia, community health 
workers and Safe Motherhood Action Groups 
were activated to track pregnancies and 
identify potential maternal deaths. Zambia, 
with continued US Government support in the 
districts that implemented SMGL, has improved 
maternal death reviews and implemented 
the WHO-recommended MDSR system. The 
lessons learned from implementing SMGL 
are being used to strengthen the community 
surveillance reporting system of maternal deaths.
Implementing International Classification  
of Diseases, Tenth Revision (ICD-10) 
Classification of Deaths  
An essential capacity that was missing in both 
countries was the ability of health providers 
to correctly identify the cause of death (COD). 
As a result, CDC trained several doctors on 
ICD-10 to help with the certification of causes 
of death, coding, and analyses of mortality 
data. Trained physicians were instrumental in 
certifying causes of death using information 
from verbal autopsies. They worked in pairs, 
independently assigning a COD for each death 
from the verbal autopsy questionnaires. 
Strengthening Health Management  
Information Systems  
As much as possible, SMGL sought to strengthen 
existing country government data systems 
rather than develop parallel data systems. SMGL 
helped to improve the quality of maternal 
health indicator tracking in Uganda’s District 
Health Information System 2 (DHIS2). Prior to 
SMGL, DHIS2 only collected data on maternal 
complications and deaths from the maternity 
registers, which were often incomplete. 
When the individual-level facility outcome 
data were collected through SMGL efforts, more 
maternal deaths and complications were found 
by triangulating information from several other 
registers with maternal death notifications and 
audits. This revealed that DHIS2 had substantially 
under-reported the number of maternal 
complications and deaths in these health facilities, 
and thus the information that health decision 
makers were using to assess facility performance 
was inaccurate. Based on this information
 
 
The records clerks and health workers 
responsible for reporting national 
data in the four districts were trained 
in HMIS expectations, which greatly 
improved data collection. 
Two districts hired additional 
biostatisticians and records clerks. 
These actions are expected to have lasting 
improvements in the quality of HMIS information. 
In Zambia, SMGL M&E activities strengthened 
the government HMIS’ ability to measure and 
report delivery and outcomes of maternal 
and newborn health care services, which 
facilitated decision making. Data extraction 
and documentation to capture maternal health 
indicators improved, and documentation of 
maternal deaths and complications increased. 
Producing Data Useful for Action  
The Health Facilities Assessments provided a 
relatively low-cost mechanism to obtain useful 
information for policy and decision-makers 
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to prioritize health facility needs and to begin 
addressing them. In Phase 1, this information 
was used to inform the procurement of  
essential supplies and equipment that were 
lacking in the health facilities. Because of 
the rapid start-up in Phase 1, the valuable 
information in the Health Facility Assessments 
was not used as fully as it could be in Phase 2. 
Lessons Learned from SMGL Phase 1 M&E  
and Recommendations for Phase 2 
At the conclusion of SMGL Phase 1 in May,  






How the M&E activities rolled out in  
each country. 
The main lessons learned from the  
pilot year. 
How these lessons could be applied to 
mprove and streamline M&E for Phase 2  
of SMGL. 
These findings are summarized in 
two internal reports, titled the “Phase 1: 
Monitoring and Evaluation Lessons Learned 
and Phase 2 Recommendations and Phase 
2: Monitoring and Evaluation Approaches.” 
These documents capture the key data 
collection and analysis processes and the 
timing employed in Phase 1, as well as the 
challenges encountered and the lessons 
learned. They also provide recommendations 
for refining the M&E approaches in Phase 2. 
Examining the accomplishments of M&E 
efforts through a critical lens allows SMGL to 
build on the knowledge and experiences gained 
during Phase 1. It will also allow SMGL to 
apply lessons learned to M&E approaches for 
Phase 2 in both the new expansion districts and 
countries and in the original eight pilot districts. 
Selected lessons and key recommendations 
from the “Phase 2: Monitoring and Evaluation 
Approach” report are outlined in this section.  
Lesson Learned from the Accelerated Start-Up: 
Launching so many activities in a short time 
required a huge organizational effort and the 
focused participation of many partners. A key 
challenge was insufficient time at the outset 
to coordinate and standardize M&E methods, 
processes, and data collection tools. This 
hampered coordination among partners and 
resulted in delays in data availability. It also 
hindered involvement by the MOH and district 
staff. In Phase 2, SMGL countries have the 
opportunity to plan more deliberately.
Recommendation for Phase 2 —  
Adopt a Phased Approach:  
SMGL should use a more phased approach in 
new districts, collecting baseline data well ahead 
of launching SMGL interventions, so that the 
information can be used to refine intervention 
approaches. Partners need to negotiate the 
SMGL data needs, and data collection guidelines 
and frequency before interventions begin. 
Lesson Learned About Measuring  
Maternal Deaths:  
Establishing baseline and endline maternal 
mortality levels for the two countries was 
essential to documenting the “proof of 
concept” for SMGL. Implementing routine 
maternal mortality identification required 
significant training and logistics, and involved 
the collaboration of multiple organizations. 
The endeavor built capacity and produced 
valuable information to examine change 
in maternal mortality, but not within 
the optimistic timeframes established 
early on in the SMGL pilot initiative. 
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Recommendation for Phase 2 — Invest in Long-
Term Strategies to Achieve Maternal Mortality 
Surveillance and Response:  
SMGL Phase 1 efforts created a foundation 
for continued monitoring and reporting of 
maternal deaths. Sustaining these efforts 
will require commitment by the MOHs 
and ongoing investments, particularly in 
supporting community health workers and 
their supervision. In Phase 2, data on maternal 
and newborn deaths should be collected from 
both facility and community levels from the 
onset of the project, with a more explicit focus 
on establishing a MDSR system, as well as on 
improved perinatal mortality surveillance. 
Lesson Learned About Harmonizing SMGL  
M&E Indicators, Methods, and Tools:  
Because of the rapid start-up, the countries had 
to develop their operational and M&E plans 
before there was an overall agreement on a core 
set of indicators. The lack of standardization (e.g., 
indicators, tools, data collection approaches) 
made data comparability challenging, and limited 
SMGL’s ability to fully articulate the initiative’s 
progress across the pilot districts and countries. 
Recommendation for Phase 2 —  
Coordinate around a unified M&E plan:  
In Phase 2, SMGL countries should strive 
for greater harmonization of monitoring 
and evaluation activities. Phase 2 M&E 
partners should adopt a core set of 
indicators and agree upon more specific 
procedures for data collection and reporting. 
New partner organizations joining SMGL 
should receive clear and consistent M&E 
guidance prior to implementation. 
Lesson Learned About Building  
on District Systems:  
Phase 1 had promising strategies for helping 
districts to strengthen facility-level data and HMIS 
systems, maternal death identification and review 
(including verbal autopsies), and private sector 
data. SMGL M&E activities strengthened health 
information systems and built district capacity 
in data collection. Perhaps more importantly, 
SMGL data are now available to help improve 
quality of care and inform programmatic 
decisions. In Phase 1, SMGL activities were not 
always accounted for in the regular work flow 
and job descriptions. Making these systems 
sustainable will require dedicated resources. 
Recommendation for Phase 2 —  
Invest in Information Systems and Build M&E 
Capacity to Achieve Lasting Improvements:  
In order for SMGL M&E activities to achieve 
lasting improvements in district information 
systems, the efforts need to be provided with 
adequate training and staffing. Sustaining 
improvements in community-based and facility-
based data systems, and harmonizing SMGL 
efforts with government priorities, will require 
early and continued involvement and the buy-in 
of local, district, and national governments.
15Monitoring and Evaluation Overview
Appendix:  
SMGL Phase 1 Reporting Indicators 
Category SMGL Reporting Indicator
District Population Data District population
Number of communities in each SMGL district
Number of births in each SMGL district
Mortality Number of maternal deaths in district
Number of maternal deaths in district facilities









Facility maternal case fatality rate in Emergency Obstetric and Newborn Care (EmONC)  
facilities (cause-specific)
Number of neonatal deaths (in a facility)
Availability and Quality of 
Obstetric and Newborn Care
Met need for EmONC 
Number of deliveries taking place in an EmONC health facility
Number of facilities where the 7 signal functions that constitute  
Basic EmONC (BEmONC) are functional
Number of facilities where the 9 signal functions that constitute Comprehensive EmONC  
services (CEmONC) are functional
Number of women within 2 hours of EmONC
Number of women delivering in a facility (any)
Number of women who stayed in a mother’s shelter prior to delivery in a facility
Number of women who deliver in a facility that receive counseling on family planning
Number of women who deliver in a facility that receive immediate postpartum contraception
Number of women provided with prophylactic postpartum uterotonics





Number of Cesarean sections performed
Number of newborns successfully resuscitated
Number of infants breastfed within one hour of birth
16 Monitoring and Evaluation Overview
Category SMGL Reporting Indicator
HIV Testing and Treatment 
for Women and Infants
Percentage of pregnant women tested for HIV and know their result
Number of HIV-positive pregnant women who receive antiretroviral drugs or antiretroviral 
therapy to reduce mother-to-child transmission
Number of HIV-exposed infants receiving early infant diagnosis within 2 months
Percentage of infants born to HIV-positive pregnant women who are started on Cotrimoxazole 
(CTX), prophylaxis within 2 months of birth
Percentage of infants born to HIV-positive women who receive virological testing  
in the first 2 months








Surgical Obstetric care 
Anesthesia 
Number of new health care workers who graduated from a pre-service training  
institution within the reporting timeframe




Number of communities that have trained volunteers to promote institutional delivery
Number of community members/volunteers trained to promote delivery in a facility and  
to report maternal deaths
Transportation and Vouchers Number of communities where pregnant women have access to a functional transportation 
system or scheme for emergency referral
Number of ambulances provided to a district
Number of ambulance motorcycles provided to a district
Number of ambulance bicycles provided to a district
Number of vouchers for transportation to a health facility distributed to women
Number of vouchers for transportation to a health facility redeemed
Number of vouchers for labor and delivery services distributed to women
Number of vouchers for labor and delivery services redeemed
Other Number of clean birth kits distributed
Number of radio spots promoting delivery in a facility broadcast
Number of times any SMGL radio spots were broadcast
Number of maternity wards refurbished/expanded
Number of mothers’ shelters renovated

For more information, please contact
Centers for Disease Control and Prevention
Division of Reproductive Health, Mailstop F-74
1600 Clifton Road NE, Atlanta, GA 30333
Telephone: 1-800-CDC-INFO (232-4636) / TTY: 1-888-232-6348
E-mail: cdcinfo@cdc.gov 
Web: http://www.cdc.gov
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